Clinical Trials on Implantable Cardioverter-Defibrillator in Canada

Total 11 results

Boston Scientific Corporation

Completed

LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices

Implantable Cardioverter Defibrillators | CRT-D Cardiac Resynchronization Therapy Defibrillator

Korea, Republic of, United States, United Kingdom, Japan, Germany, Canada, Spain, Switzerland
MicroPort CRM

Completed

Clinical and Device Functional Assessment of Real World ICD Patients (CARAT)

Arrythmia | Implantable Cardioverter Defibrillator

Spain, United Kingdom, France, Netherlands, Canada, Czechia, Germany, Italy, Switzerland, Portugal, Austria, Slovakia
Medtronic Cardiac Rhythm and Heart Failure

Completed

Confirmatory Clinical Trial of the Evera MRI System for Conditionally-safe MRI Access

Implantable Defibrillator

Saudi Arabia, United States, Hong Kong, Switzerland, Sweden, Canada, Germany, Netherlands, Belgium, Hungary, India, Chile, Italy
Forest Laboratories

Terminated

Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2) (SHIELD-2)

Heart Diseases | Cardiovascular Diseases | Arrhythmias, Cardiac | Implantable Cardioverter Defibrillator

United States, Belgium, Canada, Czech Republic, Denmark, France, Germany, Israel, Italy, Netherlands, Poland, Spain, Sweden
Unity Health Toronto
Applied Health Research Centre; Biotronik Canada Inc

Active, not recruiting

Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead (Dx-AF)

Cardiovascular Diseases | Implantable Cardioverter-Defibrillators | Cardiac Arrhythmias | Atrial Fibrillation and Flutter

Canada
Nova Scotia Health Authority
Maritime Heart Centre

Recruiting

END - VT Cohort Study (END VT)

Ventricular Tachycardia | Implantable Defibrillator User | ICD

Canada
Population Health Research Institute
Hamilton Health Sciences Corporation; Abbott Medical Devices

Terminated

Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia (CEASE-VT)

Tachycardia, Ventricular | Defibrillators, Implantable

United States, Canada, China
Boston Scientific Corporation

Completed

Precision Event Monitoring for Patients With Heart Failure Using HeartLogic (PREEMPT-HF)

Heart Failure | Cardiovascular Disease | Heart Disease | Defibrillators, Implantable | Cardiac Resynchronization Therapy | Monitoring, Physiologic

United States, Spain, United Kingdom, Netherlands, Hong Kong, Denmark, France, Ireland, Australia, Belgium, Canada, Germany, Italy
University of Calgary
Canadian Institutes of Health Research (CIHR); Hoffmann-La Roche; Medtronic; Cambridge...

Completed

Effect of Targeting Left Ventricular Lead Position on the Rate of Response to Cardiac Resynchronization Therapy. (INCREMENTAL)

Heart Failure, Congestive | Cardiac Pacing, Artificial | Defibrillators

Canada
University of British Columbia

Unknown

Intrawound Vancomycin Prophylaxis for Neural Stimulator (IV-DIRT)

Surgical Site Infection | Deep Brain Stimulation | Vancomycin | Implantable Neural Stimulator

Canada
MicroPort CRM

Active, not recruiting

Observational Study on Inappropriate Therapies (OSIRIS)

Inappropriate Shocks From Implanted Defibrillator | ICD Replacement or Upgrade

Netherlands, United States, France, Spain, Belgium, Switzerland, Italy, United Kingdom, Germany, Austria, Portugal

Clinical Trials on Implantable Cardioverter-Defibrillator in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations